In its April 2019 NEWSletter, the Patented Medicine Prices Review Board (PMPRB) announced that the Steering Committee on Guidelines Modernization would hold its final meeting on May 13, 2019, to discuss both a draft report of its deliberations and the Working Group’s final report (released March 6, 2019). Once the Steering Committee’s report has been finalized and the regulatory amendments have been published in Part II of the Canada Gazette (expected this spring), the PMPRB will release its draft Guidelines for public consultation.
Related Publications & Articles
-
Pharmaceutical and Life Sciences Sector Task Force submits final report to the Ministers of Health and Industry
On July 24, 2026, the Pharmaceutical and Life Sciences Sector Task Force (the “Task Force”) published its final report to the Ministers of Health and Industry pursuant to a mandate to (i) explore inno...Read More -
Canada’s Drug Agency: guidance document on use of AI methods & summary of precision medicine initiatives
In July 2026, Canada’s Drug Agency (CDA) published Use of Artificial Intelligence Methods to Generate Real-World Evidence Submitted to Canada’s Drug Agency for HTA. This guidance document describes pr...Read More -
PMPRB consults further on revised proposed practice directions
The Patented Medicine Prices Review Board (PMPRB) holds public hearings on two types of mattersRead More
